AAAAAA

   
Results: 1-19 |
Results: 19
CHRONIC HALOPERIDOL TREATMENT DOES NOT AFFECT STRUCTURE OF ATTENTION IN SCHIZOPHRENIA
Authors: ALLEN DN GILBERTSON MW VANKAMMEN DP KELLEY ME GURKLIS JA BARRY EJ
Citation: Dn. Allen et al., CHRONIC HALOPERIDOL TREATMENT DOES NOT AFFECT STRUCTURE OF ATTENTION IN SCHIZOPHRENIA, Schizophrenia research, 25(1), 1997, pp. 53-61
SUBSTANCE-ABUSE AND NEUROCOGNITIVE FUNCTION IN SCHIZOPHRENIA
Authors: ALLEN DN GILBERTSON MW SEATON BE GURKLIS JA BARRY EJ VANKAMMEN DP
Citation: Dn. Allen et al., SUBSTANCE-ABUSE AND NEUROCOGNITIVE FUNCTION IN SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 95-96
EFFECTS OF HALOPERIDOL ON STRUCTURE OF ATTENTION IN SCHIZOPHRENIA
Authors: ALLEN DN GILBERTSON MW VANKAMMEN DP
Citation: Dn. Allen et al., EFFECTS OF HALOPERIDOL ON STRUCTURE OF ATTENTION IN SCHIZOPHRENIA, Archives of clinical neuropsychology, 12(4), 1997, pp. 281-282
RECENT AND REMOTE MEMORY DISSOCIATION - MEDICATION EFFECTS AND HIPPOCAMPAL FUNCTION IN SCHIZOPHRENIA
Authors: GILBERTSON MW VANKAMMEN DP
Citation: Mw. Gilbertson et Dp. Vankammen, RECENT AND REMOTE MEMORY DISSOCIATION - MEDICATION EFFECTS AND HIPPOCAMPAL FUNCTION IN SCHIZOPHRENIA, Biological psychiatry, 42(7), 1997, pp. 585-595
PREDICTING DURATION OF CLINICAL STABILITY FOLLOWING HALOPERIDOL WITHDRAWAL IN SCHIZOPHRENIA
Authors: VANKAMMEN DP KELLEY ME GURKLIS JA GILBERTSON MW YAO JK CONDRAY R PETERS JL
Citation: Dp. Vankammen et al., PREDICTING DURATION OF CLINICAL STABILITY FOLLOWING HALOPERIDOL WITHDRAWAL IN SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 2-2
CSF OXYTOCIN-NEUROPHYSIN AND VASOPRESSIN-NEUROPHYSIN IN SCHIZOPHRENIA- RELATIONSHIPS WITH STATE AND TRAIT VARIABLES
Authors: VANKAMMEN DP LEGROS JJ KELLEY ME YAO JK GILBERTSON MW CONDRAY R GURKLIS JA PETERS JL
Citation: Dp. Vankammen et al., CSF OXYTOCIN-NEUROPHYSIN AND VASOPRESSIN-NEUROPHYSIN IN SCHIZOPHRENIA- RELATIONSHIPS WITH STATE AND TRAIT VARIABLES, Schizophrenia research, 18(2-3), 1996, p.
PREDICTING DURATION OF CLINICAL STABILITY FOLLOWING HALOPERIDOL WITHDRAWAL IN SCHIZOPHRENIC-PATIENTS
Authors: VANKAMMEN DP KELLEY ME GURKLIS JA GILBERTSON MW YAO JK CONDRAY R PETERS JL
Citation: Dp. Vankammen et al., PREDICTING DURATION OF CLINICAL STABILITY FOLLOWING HALOPERIDOL WITHDRAWAL IN SCHIZOPHRENIC-PATIENTS, Neuropsychopharmacology, 14(4), 1996, pp. 275-283
PREDICTING HALOPERIDOL TREATMENT RESPONSE IN CHRONIC-SCHIZOPHRENIA
Authors: VANKAMMEN DP KELLEY ME YAO JK GILBERTSON MW GURKLIS JA INOSAKA T SAITO H PETERS JL SATO M
Citation: Dp. Vankammen et al., PREDICTING HALOPERIDOL TREATMENT RESPONSE IN CHRONIC-SCHIZOPHRENIA, Psychiatry research, 64(1), 1996, pp. 47-58
MAGNETIC-RESONANCE-IMAGING STUDY OF HIPPOCAMPAL VOLUME IN CHRONIC, COMBAT-RELATED POSTTRAUMATIC-STRESS-DISORDER
Authors: GURVITS TV SHENTON ME HOKAMA H OHTA H LASKO NB GILBERTSON MW ORR SP KIKINIS R JOLESZ FA MCCARLEY RW PITMAN RK
Citation: Tv. Gurvits et al., MAGNETIC-RESONANCE-IMAGING STUDY OF HIPPOCAMPAL VOLUME IN CHRONIC, COMBAT-RELATED POSTTRAUMATIC-STRESS-DISORDER, Biological psychiatry, 40(11), 1996, pp. 1091-1099
PREDICTING HALOPERIDOL TREATMENT RESPONSE IN CHRONIC-SCHIZOPHRENIA
Authors: VANKAMMEN DP KELLEY ME YAO JK GILBERTSON MW GURKLIS JA INOSAKA T PETERS JL
Citation: Dp. Vankammen et al., PREDICTING HALOPERIDOL TREATMENT RESPONSE IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 72-73
PREDICTION OF RELAPSE RISK OVER TIME FOLLOWING HALOPERIDOL WITHDRAWALIN SCHIZOPHRENIA
Authors: VANKAMMEN DP KELLEY ME GURKLIS JA GILBERTSON MW YAO JK PETERS JL
Citation: Dp. Vankammen et al., PREDICTION OF RELAPSE RISK OVER TIME FOLLOWING HALOPERIDOL WITHDRAWALIN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 73-73
BEHAVIORAL VS BIOCHEMICAL PREDICTION OF CLINICAL STABILITY FOLLOWING HALOPERIDOL WITHDRAWAL IN SCHIZOPHRENIA
Authors: VANKAMMEN DP KELLEY ME GURKLIS JA GILBERTSON MW YAO JK PETERS JL
Citation: Dp. Vankammen et al., BEHAVIORAL VS BIOCHEMICAL PREDICTION OF CLINICAL STABILITY FOLLOWING HALOPERIDOL WITHDRAWAL IN SCHIZOPHRENIA, Archives of general psychiatry, 52(8), 1995, pp. 673-678
CSF LEVELS OF DIAZEPAM-BINDING INHIBITOR CORRELATE WITH REM LATENCY IN SCHIZOPHRENIA, A PILOT-STUDY
Authors: VANKAMMEN DP GUIDOTTI A NEYLAN T GUARNERI P KELLEY ME GURKLIS J GILBERTSON MW PETERS JL COSTA E
Citation: Dp. Vankammen et al., CSF LEVELS OF DIAZEPAM-BINDING INHIBITOR CORRELATE WITH REM LATENCY IN SCHIZOPHRENIA, A PILOT-STUDY, European archives of psychiatry and clinical neuroscience, 244(4), 1994, pp. 216-222
BEHAVIORAL VS BIOCHEMICAL PREDICTION OF RELAPSE FOLLOWING HALOPERIDOLWITHDRAWAL IN SCHIZOPHRENIA
Authors: VANKAMMEN DP KELLEY ME GURKLIS JA GILBERTSON MW PETERS JL
Citation: Dp. Vankammen et al., BEHAVIORAL VS BIOCHEMICAL PREDICTION OF RELAPSE FOLLOWING HALOPERIDOLWITHDRAWAL IN SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 116-116
A CLINICAL AND BIOCHEMICAL-MODEL OF RELAPSE PREDICTION IN SCHIZOPHRENIA - A ROLE FOR CSF INTERLEUKIN-2
Authors: VANKAMMEN DP MCALLISTER C YAO JK KELLEY ME GILBERTSON MW GURKLIS JA PETERS JL
Citation: Dp. Vankammen et al., A CLINICAL AND BIOCHEMICAL-MODEL OF RELAPSE PREDICTION IN SCHIZOPHRENIA - A ROLE FOR CSF INTERLEUKIN-2, Schizophrenia research, 11(2), 1994, pp. 128-128
MEMORY AND PLASMA HVA CHANGES IN SCHIZOPHRENIA - ARE THEY EPISODE MARKERS
Authors: GILBERTSON MW YAO JK VANKAMMEN DP
Citation: Mw. Gilbertson et al., MEMORY AND PLASMA HVA CHANGES IN SCHIZOPHRENIA - ARE THEY EPISODE MARKERS, Biological psychiatry, 35(3), 1994, pp. 203-206
CSF DOPAMINE-BETA-HYDROXYLASE IN SCHIZOPHRENIA - ASSOCIATIONS WITH PREMORBID FUNCTIONING AND BRAIN COMPUTERIZED-TOMOGRAPHY SCAN MEASURES
Authors: VANKAMMEN DP KELLEY ME GILBERTSON MW GURKLIS J OCONNOR DT
Citation: Dp. Vankammen et al., CSF DOPAMINE-BETA-HYDROXYLASE IN SCHIZOPHRENIA - ASSOCIATIONS WITH PREMORBID FUNCTIONING AND BRAIN COMPUTERIZED-TOMOGRAPHY SCAN MEASURES, The American journal of psychiatry, 151(3), 1994, pp. 372-378
CSF DIAZEPAM-BINDING INHIBITOR AND SCHIZOPHRENIA - CLINICAL AND BIOCHEMICAL RELATIONSHIPS
Authors: VANKAMMEN DP GUIDOTTI A KELLEY ME GURKLIS J GUARNERI P GILBERTSON MW YAO JK PETERS J COSTA E
Citation: Dp. Vankammen et al., CSF DIAZEPAM-BINDING INHIBITOR AND SCHIZOPHRENIA - CLINICAL AND BIOCHEMICAL RELATIONSHIPS, Biological psychiatry, 34(8), 1993, pp. 515-522
ELECTROENCEPHALOGRAPHIC SLEEP IN CLINICALLY STABLE SCHIZOPHRENIC-PATIENTS - 2-WEEKS VERSUS 6-WEEKS NEUROLEPTIC-FREE
Authors: NOFZINGER EA VANKAMMEN DP GILBERTSON MW GURKLIS JA PETERS JL
Citation: Ea. Nofzinger et al., ELECTROENCEPHALOGRAPHIC SLEEP IN CLINICALLY STABLE SCHIZOPHRENIC-PATIENTS - 2-WEEKS VERSUS 6-WEEKS NEUROLEPTIC-FREE, Biological psychiatry, 33(11-12), 1993, pp. 829-835
Risultati: 1-19 |